Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

Abstract Purpose Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but uncertain clinical value. Previous research has documented variability in academic oncologists’ perceptions and use of GTT, but little is known about community oncologists’ perceptions of GTT an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eric C. Anderson, Alexandra C. Hinton, Christine W. Lary, Anny T. H. R. Fenton, Andrey Antov, Emily Edelman, Petra Helbig, Kate Reed, Susan Miesfeldt, Christian A. Thomas, Michael J. Hall, J. Scott Roberts, Jens Rueter, Paul K. J. Han, MCGI Working Group
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Genomic Cancer Uncertainty Attitudes Confidence Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/dbabf7f6cf97472f85681b1a23bd2da2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

Ejemplares similares